Renaissance Technologies LLC Sells 22,900 Shares of American Vanguard Co. (NYSE:AVD)

Renaissance Technologies LLC trimmed its position in American Vanguard Co. (NYSE:AVD) by 7.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 279,552 shares of the basic materials company’s stock after selling 22,900 shares during the period. Renaissance Technologies LLC owned 1.00% of American Vanguard worth $2,404,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in AVD. Gladius Capital Management LP bought a new stake in shares of American Vanguard during the 2nd quarter valued at $32,000. Nisa Investment Advisors LLC boosted its stake in American Vanguard by 7,554.5% during the second quarter. Nisa Investment Advisors LLC now owns 4,210 shares of the basic materials company’s stock worth $36,000 after acquiring an additional 4,155 shares in the last quarter. Allspring Global Investments Holdings LLC bought a new stake in American Vanguard during the second quarter worth about $118,000. EntryPoint Capital LLC grew its holdings in American Vanguard by 363.9% in the first quarter. EntryPoint Capital LLC now owns 10,118 shares of the basic materials company’s stock worth $131,000 after purchasing an additional 7,937 shares during the period. Finally, Aristides Capital LLC bought a new position in shares of American Vanguard during the fourth quarter valued at approximately $132,000. Institutional investors own 79.04% of the company’s stock.

Insider Buying and Selling at American Vanguard

In related news, Director Keith M. Rosenbloom purchased 25,000 shares of American Vanguard stock in a transaction dated Tuesday, September 3rd. The stock was purchased at an average cost of $5.94 per share, for a total transaction of $148,500.00. Following the completion of the purchase, the director now directly owns 1,193,682 shares of the company’s stock, valued at approximately $7,090,471.08. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, Director Keith M. Rosenbloom bought 33,555 shares of the stock in a transaction on Wednesday, August 28th. The shares were bought at an average price of $5.66 per share, with a total value of $189,921.30. Following the completion of the acquisition, the director now owns 1,047,410 shares in the company, valued at $5,928,340.60. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Keith M. Rosenbloom bought 25,000 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was purchased at an average cost of $5.94 per share, for a total transaction of $148,500.00. Following the completion of the transaction, the director now directly owns 1,193,682 shares of the company’s stock, valued at approximately $7,090,471.08. The disclosure for this purchase can be found here. In the last 90 days, insiders have purchased 163,047 shares of company stock worth $938,205. Company insiders own 10.10% of the company’s stock.

American Vanguard Stock Performance

Shares of AVD opened at $5.14 on Wednesday. The company has a market cap of $143.70 million, a price-to-earnings ratio of 19.75 and a beta of 0.88. The business’s fifty day simple moving average is $6.49 and its two-hundred day simple moving average is $8.87. American Vanguard Co. has a 12 month low of $4.95 and a 12 month high of $14.28. The company has a current ratio of 2.22, a quick ratio of 1.08 and a debt-to-equity ratio of 0.60.

American Vanguard (NYSE:AVD) last released its quarterly earnings data on Thursday, August 8th. The basic materials company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.08). American Vanguard had a negative net margin of 0.60% and a positive return on equity of 1.85%. The business had revenue of $128.21 million for the quarter, compared to analysts’ expectations of $134.20 million. Research analysts anticipate that American Vanguard Co. will post 0.02 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Lake Street Capital assumed coverage on American Vanguard in a research report on Monday, July 22nd. They issued a “buy” rating and a $14.00 price target on the stock. StockNews.com raised shares of American Vanguard from a “sell” rating to a “hold” rating in a research report on Wednesday, September 25th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $16.67.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.